Analytic Investors’s CR Bard Inc. BCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$11.9M Sell
53,112
-43,729
-45% -$9.84M 0.13% 147
2016
Q2
$22.8M Hold
96,841
0.27% 90
2016
Q1
$19.6M Sell
96,841
-66
-0.1% -$12.5K 0.24% 95
2015
Q4
$18.4M Buy
96,907
+78,390
+423% +$14.7M 0.23% 100
2015
Q3
$3.45M Sell
18,517
-2,197
-11% -$416K 0.05% 226
2015
Q2
$3.54M Sell
20,714
-7,941
-28% -$1.36M 0.05% 207
2015
Q1
$4.79M Sell
28,655
-9,041
-24% -$1.55M 0.07% 167
2014
Q4
$6.28M Sell
37,696
-13,298
-26% -$2.15M 0.09% 162
2014
Q3
$7.28M Buy
50,994
+9,919
+24% +$1.47M 0.1% 156
2014
Q2
$5.88M Buy
41,075
+10,283
+33% +$1.47M 0.1% 159
2014
Q1
$4.56M Buy
30,792
+27,510
+838% +$3.81M 0.07% 194
2013
Q4
$440K Sell
3,282
-848
-21% -$112K 0.01% 398
2013
Q3
$476K Buy
+4,130
New +$474K 0.01% 389

Other funds holding BCR

Analytic Investors's BCR Position: Q3 2016 in Review

Analytic Investors reduced its CR Bard Inc. (BCR) stake by 45% in Q3 2016, selling an estimated $9.84M and leaving 53,112 shares worth $11.9M. The position accounts for 0.13% of the portfolio, ranked #147.

Analytic Investors first reported a position in BCR in Q3 2013 and has held it in 13 quarters since. The position peaked at $22.8M in Q2 2016. 630 funds tracked by Wall St. Rank hold BCR as of Q3 2016.

  • Analytic Investors held 53,112 shares of CR Bard Inc. worth $11.9M as of Q3 2016.
  • Analytic Investors sold 43,729 CR Bard Inc. shares in Q3 2016, an estimated $9.84M.
  • CR Bard Inc. made up 0.13% of Analytic Investors's portfolio in Q3 2016, its #147 holding.
  • Analytic Investors first reported a position in CR Bard Inc. in Q3 2013 and has held it in 13 quarters since.
  • Analytic Investors's CR Bard Inc. position peaked at $22.8M in Q2 2016.
  • 630 funds tracked by Wall St. Rank held CR Bard Inc. as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.